Valuation: aap Implantate AG

Market Cap 21.98M 25.41M 20.52M 18.83M 35.41M 2.42B 35.97M 241M 94.51M 1.21B 95.41M 93.32M 4.01B P/E 2024
-3.6x
P/E 2025 -7.58x
Enterprise Value 21.66M 25.04M 20.23M 18.56M 34.91M 2.38B 35.46M 237M 93.16M 1.19B 94.04M 91.99M 3.95B EV / Sales 2024
1.31x
EV / Sales 2025 1.52x
Free-Float
38.21%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2019-04-30
Director TitleAgeSince
Director/Board Member 70 2015-12-31
Chairman 54 2019-07-03
Director/Board Member 50 2021-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-9.32% - - 25.41M
-0.14%+2.00%-19.71%+2.11% 187B
+1.44%+2.07%-6.16%+5.98% 112B
-1.40%+2.93%+12.39%+72.88% 61.15B
+0.65%+3.91%+32.37%+55.21% 54.39B
-0.12%+6.79%-8.60%-37.08% 48.17B
+2.08%+1.56%+7.47%-23.09% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+46.93%-11.45% 24.92B
+2.45%+3.97%-2.22%+5.43% 23.14B
Average +0.59%+1.45%+7.81%+8.75% 63.64B
Weighted average by Cap. +0.53%+2.02%-1.67%+10.77%

Financials

2024 2025
Net sales 12.29M 14.21M 11.48M 10.53M 19.81M 1.35B 20.12M 135M 52.86M 678M 53.37M 52.2M 2.24B 12.8M 14.8M 11.96M 10.97M 20.63M 1.41B 20.96M 140M 55.06M 706M 55.59M 54.37M 2.33B
Net income -3.63M -4.2M -3.39M -3.11M -5.85M -399M -5.94M -39.77M -15.61M -200M -15.76M -15.41M -662M -2.58M -2.99M -2.41M -2.21M -4.17M -284M -4.23M -28.32M -11.12M -143M -11.22M -10.98M -471M
Net Debt -1.1M -1.27M -1.03M -943K -1.77M -121M -1.8M -12.06M -4.73M -60.72M -4.78M -4.68M -201M -314K -363K -293K -269K -506K -34.55M -514K -3.44M -1.35M -17.32M -1.36M -1.33M -57.25M
Logo aap Implantate AG
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Employees
-